Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments (IVHSP) (CDC-RFA-PS21-2103): Component 3 [DRAFT]

Draft 1 of 2

By completing special projects for people who inject drugs (PWID), funded jurisdictions will help improve infectious disease outcomes for PWID

Strategies for Improving Infectious Disease Outcomes for PWID

Improve access to services for PWID in settings that serve PWID by …

Activities that Improve Access to Services for PWID

… developing and implementing a ‘PWID service bundle’ …

… in settings that serve PWID
e.g., syringe service programs (SSPs), substance use disorder (SUD) treatment facilities, hospital settings, correctional facilities

Completion of these activities will contribute to …

Outcomes of Implementing ‘PWID Service Bundle’ Activities

Increased access to high-coverage needle-syringe exchange among PWID

Increased linkage to SUD treatment (including MOUD for PWID with OUD)

Increased HCV, HIV, and HBV testing among PWID

Increased linkage to treatment services among people with infectious diseases caused by injection drug use

Increased receipt of hepatitis B and A vaccination among PWID

Decreased new viral hepatitis, HIV and other infections (e.g., bacterial, fungal) among PWID

Increased hepatitis C cures among PWID with hepatitis C

Acronyms:
HBV: hepatitis B virus
HCV: hepatitis C virus
HIV: human immunodeficiency virus
MOUD: medication for opioid use disorder
SSP: syringe service program
SUD: substance use disorder

Draft 2 of 2

By completing special projects for people who inject drugs (PWID), funded jurisdictions will help improve infectious disease outcomes for PWID

Strategies for Improving Infectious Disease Outcomes for PWID

Improve access to services for PWID in settings that serve PWID by …

Activities that Improve Access to Services for PWID

… developing and implementing a ‘PWID service bundle’ …

… in settings that serve PWID
e.g., syringe service programs (SSPs), substance use disorder (SUD) treatment facilities, hospital settings, correctional facilities

Completion of these activities will contribute to …

Outcomes of Implementing ‘PWID Service Bundle’ Activities

Increased access to high-coverage needle-syringe exchange among PWID

Increased linkage to SUD treatment (including MOUD for PWID with OUD)

Increased HCV, HIV, and HBV testing among PWID

Increased linkage to treatment services among people with infectious diseases caused by injection drug use

Increased receipt of hepatitis B and A vaccination among PWID

Decreased new viral hepatitis, HIV and other infections (e.g., bacterial, fungal) among PWID

Increased hepatitis C cures among PWID with hepatitis C

‘PWID Service Bundle’

A ‘PWID service bundle’ is a list of services designed to prevent, mitigate or treat infectious complications of injection drug use. Local jurisdictions can prioritize which services are most important for their populations. PWID service bundles include access (directly or through referral) to the following components:

Testing for hepatitis C virus (HCV), hepatitis B virus (HBV) and human immunodeficiency virus (HIV)

Annual HCV testing is recommended for PWID with no prior testing, or past negative testing and subsequent injection drug use. PWID with unknown HBV status should be tested for anti-HBs, anti-HBc and HBsAg. PWID not known to be HIV positive should have HIV testing on an annual basis.

Treatment for infectious diseases (viral, bacterial, and fungal)

Hepatitis C treatment is recommended for all persons with acute or chronic HCV infection and ‘active or recent drug use or a concern for reinfection is not a contraindication to HCV treatment.’ All persons with chronic HBV infection should be followed indefinitely by a knowledgeable physician. Antiretroviral therapy (ART) is recommended for all persons with HIV to reduce morbidity and mortality and to prevent the transmission of HIV to others.

State-level projects

Awardee Name: Colorado Department of Public Health and Environment

Bundled service delivery settings: syringe service programs (SSPs), substance use disorder (SUD) treatment programs, hospitals/clinics, correctional settings

Summary of Project: Colorado Department of Public Health and Environment (CDPHE) will implement a community-specific, multi-agency and data-driven approach to focus its efforts to serve people who inject drugs (PWID) in three highly impacted regions. Over the next five years CDPHE will:

enhance existing SSPs and support the establishment of new SSPs
develop a Regional Provider Network to cultivate relationships with PWID providers and key stakeholders
update PWID data collection instruments to promote a data to action model

These activities will contribute to improved health outcomes for PWID by:

increasing access to culturally-responsive care and high-coverage needle-syringe exchange
decreasing injection drug use-associated infections and overdoses
increasing linkage to SUD treatment (including medication for opioid use disorder (MOUD) among PWID with OUD)
improving testing and linkage to treatment for infections associated with drug use and SUD (including hepatitis C virus (HCV), human immunodeficiency virus (HIV), hepatitis B virus (HBV), bacterial, and fungal infections)
increasing vaccination for hepatitis A and hepatitis B

Awardee Name: Florida Department of Health

Bundled service delivery settings: academic institutions, syringe service programs (SSPs), hospitals/clinics, correctional settings

Summary of Project: To make progress toward the elimination of viral hepatitis in Florida, the Department’s Hepatitis Program and key partners and stakeholders will:

make vaccination for hepatitis A and B widely available for high-risk populations
make testing for hepatitis routinely available in high volume settings
disseminate prevention education to appropriate populations
implement sustainable and replicable evidence-based interventions in clinical and non-clinical settings

By implementing these activities, the Hepatitis Program will contribute to improved health outcomes for people who inject drugs (PWID) by:

increasing provider capacity to make treatment for hepatitis B and C readily accessible
improving and increasing access to bundled services and education for PWID
reducing incidence of hepatitis and other infectious diseases and health issues related to substance use disorder